Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recombinant Destabilase from Hirudo medicinalis Is Able to Dissolve Human Blood Clots In Vitro. | Curr Issues Mol Biol | 2021 | 34889897 | PubTator, text mining | PubMed |
| Prolyl endopeptidase-like is a (thio)esterase involved in mitochondrial respiratory chain function. | iScience | 2021 | 34888501 | PubTator, text mining | PubMed |
| Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19. | Nat Commun | 2021 | 34887400 | PubTator, text mining | PubMed |
| Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis. | Biomed Res Int | 2021 | 34877354 | PubTator, text mining | PubMed |
| Hemostasis testing in patients with liver dysfunction: Advantages and caveats. | World J Gastroenterol | 2021 | 34876789 | PubTator, text mining | PubMed |
| Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis. | Nat Commun | 2021 | 34876572 | PubTator, text mining | PubMed |
| Tissue Plasminogen Activator Effects on Fibrin Volume and the Ocular Proteome in a Juvenile Rabbit Model of Lensectomy. | Transl Vis Sci Technol | 2021 | 34874448 | PubTator, text mining | PubMed |
| Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger. | Front Cardiovasc Med | 2021 | 34869682 | PubTator, text mining | PubMed |
| An Immunomodulatory Transcriptional Signature Associated With Persistent Listeria Infection in Hepatocytes. | Front Cell Infect Microbiol | 2021 | 34858876 | PubTator, text mining | PubMed |
| Site specific incidence rate of virulence related genes of enteroaggregative Escherichia coli and association with enteric inflammation and growth in children. | Sci Rep | 2021 | 34848801 | PubTator, text mining | PubMed |
| Engineering of Ocriplasmin Variants by Bioinformatics Methods for the Reduction of Proteolytic and Autolytic Activities. | Iran J Med Sci | 2021 | 34840386 | PubTator, text mining | PubMed |
| Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder. | Mob DNA | 2021 | 34838103 | PubTator, text mining | PubMed |
| Diversity of Potentially Pathogenic Escherichia coli O104 and O9 Serogroups Isolated before 2011 from Fecal Samples from Children from Different Geographic Regions. | Microorganisms | 2021 | 34835353 | PubTator, text mining | PubMed |
| TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. | J Clin Med | 2021 | 34830660 | PubTator, text mining | PubMed |
| Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics. | Int J Mol Sci | 2021 | 34830419 | PubTator, text mining | PubMed |
| Thromboelastometry in Neonates with Respiratory Distress Syndrome: A Pilot Study. | Diagnostics (Basel) | 2021 | 34829342 | PubTator, text mining | PubMed |
| Systemic Effects of Hemorrhagic Snake Venom Metalloproteinases: Untargeted Peptidomics to Explore the Pathodegradome of Plasma Proteins. | Toxins (Basel) | 2021 | 34822548 | PubTator, text mining | PubMed |
| Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi. | Sci Rep | 2021 | 34815441 | PubTator, text mining | PubMed |
| Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study. | J Immunother Cancer | 2021 | 34815354 | PubTator, text mining | PubMed |
| Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells. | iScience | 2021 | 34786537 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=45